Omnicell PE Ratio 2010-2024 | OMCL
Current and historical p/e ratio for Omnicell (OMCL) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Omnicell PE ratio as of November 11, 2024 is 74.03.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Omnicell PE Ratio Historical Data |
Date |
Stock Price |
TTM Net EPS |
PE Ratio |
2024-11-12 |
48.89 |
|
0.00 |
2024-09-30 |
43.60 |
$-0.58 |
0.00 |
2024-06-30 |
27.07 |
$-0.46 |
0.00 |
2024-03-31 |
29.23 |
$-0.46 |
0.00 |
2023-12-31 |
37.63 |
$-0.45 |
0.00 |
2023-09-30 |
45.04 |
$-0.77 |
0.00 |
2023-06-30 |
73.67 |
$-0.52 |
0.00 |
2023-03-31 |
58.67 |
$-0.40 |
0.00 |
2022-12-31 |
50.42 |
$0.10 |
504.20 |
2022-09-30 |
87.03 |
$1.02 |
85.32 |
2022-06-30 |
113.75 |
$1.26 |
90.28 |
2022-03-31 |
129.49 |
$1.49 |
86.91 |
2021-12-31 |
180.44 |
$1.62 |
111.38 |
2021-09-30 |
148.43 |
$1.71 |
86.80 |
2021-06-30 |
151.45 |
$1.30 |
116.50 |
2021-03-31 |
129.87 |
$0.77 |
168.66 |
2020-12-31 |
120.02 |
$0.73 |
164.41 |
2020-09-30 |
74.66 |
$0.87 |
85.82 |
2020-06-30 |
70.62 |
$1.13 |
62.50 |
2020-03-31 |
65.58 |
$1.60 |
40.99 |
2019-12-31 |
81.72 |
$1.42 |
57.55 |
2019-09-30 |
72.27 |
$1.27 |
56.91 |
2019-06-30 |
86.03 |
$1.14 |
75.46 |
2019-03-31 |
80.84 |
$0.93 |
86.92 |
2018-12-31 |
61.24 |
$0.92 |
66.57 |
2018-09-30 |
71.90 |
$1.18 |
60.93 |
2018-06-30 |
52.45 |
$1.01 |
51.93 |
2018-03-31 |
43.40 |
$0.87 |
49.89 |
2017-12-31 |
48.50 |
$0.51 |
95.10 |
2017-09-30 |
51.05 |
$-0.11 |
0.00 |
2017-06-30 |
43.10 |
$-0.22 |
0.00 |
2017-03-31 |
40.65 |
$-0.27 |
0.00 |
2016-12-31 |
33.90 |
$0.01 |
3390.00 |
2016-09-30 |
38.30 |
$0.22 |
174.09 |
2016-06-30 |
34.23 |
$0.39 |
87.77 |
2016-03-31 |
27.87 |
$0.66 |
42.23 |
2015-12-31 |
31.08 |
$0.84 |
37.00 |
2015-09-30 |
31.10 |
$0.88 |
35.34 |
2015-06-30 |
37.71 |
$0.86 |
43.85 |
2015-03-31 |
35.10 |
$0.83 |
42.29 |
2014-12-31 |
33.12 |
$0.83 |
39.90 |
2014-09-30 |
27.33 |
$0.77 |
35.49 |
2014-06-30 |
28.71 |
$0.78 |
36.81 |
2014-03-31 |
28.62 |
$0.74 |
38.68 |
2013-12-31 |
25.53 |
$0.67 |
38.10 |
2013-09-30 |
23.68 |
$0.64 |
37.00 |
2013-06-30 |
20.55 |
$0.63 |
32.62 |
2013-03-31 |
18.88 |
$0.50 |
37.76 |
2012-12-31 |
14.87 |
$0.47 |
31.64 |
2012-09-30 |
13.90 |
$0.43 |
32.33 |
2012-06-30 |
14.64 |
$0.32 |
45.75 |
2012-03-31 |
15.21 |
$0.36 |
42.25 |
2011-12-31 |
16.52 |
$0.31 |
53.29 |
2011-09-30 |
13.78 |
$0.21 |
65.62 |
2011-06-30 |
15.59 |
$0.16 |
97.44 |
2011-03-31 |
15.24 |
$0.14 |
108.86 |
2010-12-31 |
14.45 |
$0.15 |
96.33 |
2010-09-30 |
13.08 |
$0.15 |
87.20 |
2010-06-30 |
11.69 |
$0.14 |
83.50 |
2010-03-31 |
14.03 |
$0.11 |
127.55 |
2009-12-31 |
11.69 |
$0.02 |
584.50 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$2.263B |
$1.147B |
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|